XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Cash flows from operating activities:    
Net income (loss) $ 269,664 $ (27,338)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 77,985 78,308
Non-cash lease expense 144,347 147,198
Benefit for deferred income taxes (5,086) (15,293)
Share-based compensation expense 19,068 17,030
Store impairment   14,528
Loss on disposition of property and equipment, net 193 706
Changes in assets and liabilities:    
Receivables (24,387) 1,137
Inventory (238,094) (79,462)
Prepaid expenses and other assets (10,087) (35,403)
Payables, accrued expenses and other liabilities 161,251 235,618
Operating lease liabilities (172,575) (122,360)
Net cash provided by operating activities 222,279 214,669
Cash flows from investing activities:    
Cash paid for property and equipment (159,008) (89,153)
Cash paid for marketable securities (442,249) (93,945)
Sales and maturities of marketable securities 237,879 384,999
Net cash (used in) provided by investing activities (363,378) 201,901
Cash flows from financing activities:    
Borrowings under debt   220,000
Repayments of debt   (220,000)
Proceeds from the exercise of stock options 2,815  
Share repurchases related to share repurchase program (14,888) (7,036)
Share repurchases related to taxes for share-based awards (7,684) (3,802)
Net cash used in financing activities (19,757) (10,838)
Effect of exchange rate changes on cash and cash equivalents 1,575 (2,626)
(Decrease) increase in cash and cash equivalents (159,281) 403,106
Cash and cash equivalents at beginning of period 395,635 221,839
Cash and cash equivalents at end of period 236,354 624,945
Cash paid during the year for:    
Income taxes 81,747 11,549
Non-cash investing activities—Accrued capital expenditures $ 75,206 $ 54,137